HUDDINGE, Sweden, June 7, 2023 /PRNewswire/ — XNK Therapeutics today announced the appointment of Hugo Petit as Chief Financial Officer (CFO) and member of the company’s leadership team. Hugo Petit has extensive experience in the life sciences sector and has served as CFO in both public and privately held companies. “We are very pleased to have … Read more
HUDDINGE, Sweden, June 7, 2023 /PRNewswire/ — XNK Therapeutics today announced the appointment of Hugo Petit as Chief Financial Officer (CFO) and member of the company’s leadership team. Hugo Petit has extensive experience in the life sciences sector and has served as CFO in both public and privately held companies. “We are very pleased to have … Read more
HUDDINGE, Sweden, May 24, 2023 /PRNewswire/ — XNK Therapeutics today announced that its CEO Johan Liwing will present at ABG Sundal Collier’s Life Science Summit in Stockholm, Sweden, on May 31 at 10:00am CEST. The presentation is followed by a short Q&A session, moderated by an ABGSC analyst, and a recording will be available after the … Read more
HUDDINGE, Sweden, May 24, 2023 /PRNewswire/ — XNK Therapeutics today announced that its CEO Johan Liwing will present at ABG Sundal Collier’s Life Science Summit in Stockholm, Sweden, on May 31 at 10:00am CEST. The presentation is followed by a short Q&A session, moderated by an ABGSC analyst, and a recording will be available after the … Read more